Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN – Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.13 and traded as high as $0.20. Enzon Pharmaceuticals shares last traded at $0.19, with a volume of 683,174 shares trading hands.
Enzon Pharmaceuticals Price Performance
The business has a fifty day moving average of $0.10 and a 200-day moving average of $0.13. The stock has a market cap of $13.95 million, a PE ratio of 18.81 and a beta of 0.49.
About Enzon Pharmaceuticals
Enzon Pharmaceuticals, Inc, together with its subsidiaries, does not have significant operations. Previously, the company marketed its patented drug product, PegIntron. It also had a marketing agreement with Micromet AG relating to the Vicineum drug; and a licensing agreement regarding SC Oncaspar and certain other drugs.
See Also
- Five stocks we like better than Enzon Pharmaceuticals
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- How to Invest in the Best Canadian Stocks
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- What Are Dividend Achievers? An Introduction
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
